Skip to content
2000
Volume 25, Issue 4
  • ISSN: 1871-5206
  • E-ISSN: 1875-5992

Abstract

Background

Nitric Oxide (NO) has recently gained recognition as a promising approach in the field of cancer therapy. The quinoline scaffold is pivotal in cancer drug research and is known for its versatility and diverse mechanisms of action.

Objective

This study presents the synthesis, characterization, and evaluation of novel quinoline nitrate derivatives as potential anticancer agents.

Methods

The compounds were synthesized through a multi-step process involving the preparation of substituted 1-(2-aminophenyl) ethan-1-one, followed by the synthesis of substituted 2-(chloromethyl)-3,4-dimethylquinolines, and finally, the formation of substituted (3,4-dimethylquinolin-2-yl) methyl nitrate derivatives. The synthesized compounds were characterized using various spectroscopic techniques. Molecular docking studies were conducted to assess the binding affinity of the compounds to the EGFR tyrosine kinase domain.

Results

The docking scores revealed varying degrees of binding affinity, with compound 6k exhibiting the highest score. The results suggested a correlation between molecular docking scores and anticancer activity. Further evaluations included MTT assays to determine the cytotoxicity of the compounds against Non-Small Cell Lung Cancer (A-549) and pancreatic cancer (PANC-1) cell lines. Compounds with electron-donating groups displayed notable anticancer potential, and there was a correlation between NO release and anticancer activity. The study also investigated nitric oxide release from the compounds, revealing compound 6g as the highest NO releaser.

Conclusion

The synthesized quinoline nitrate derivatives showed promising anticancer activity, with compound 6g standing out as a potential lead compound. The correlation between molecular docking, NO release, and anticancer activity suggests the importance of specific structural features in the design of effective anticancer agents.

Loading

Article metrics loading...

/content/journals/acamc/10.2174/0118715206315415240830052608
2024-10-01
2025-02-28
Loading full text...

Full text loading...

References

  1. SiegelR.L. MillerK.D. WagleN.S. JemalA. Cancer statistics, 2023.CA Cancer J. Clin.2023731174810.3322/caac.21763 36633525
    [Google Scholar]
  2. TilsedC.M. FisherS.A. NowakA.K. LakeR.A. LesterhuisW. J. Cancer chemotherapy: insights into cellular and tumor microenvironmental mechanisms of action.Front. Oncol.20221296031710.3389/fonc.2022.960317 35965519
    [Google Scholar]
  3. MintzJ. VedenkoA. RoseteO. ShahK. GoldsteinG. HareJ.M. RamasamyR. AroraH. Current advances of nitric oxide in cancer and anticancer therapeutics.Vaccines (Basel)2021929410.3390/vaccines9020094 33513777
    [Google Scholar]
  4. SinhaB.K. Can nitric oxide-based therapy be improved for the treatment of cancers? A perspective.Int. J. Mol. Sci.202324171361110.3390/ijms241713611 37686417
    [Google Scholar]
  5. PierettiJ.C. PelegrinoM.T. NascimentoM.H.M. TortellaG.R. RubilarO. SeabraA.B. Small molecules for great solutions: Can nitric oxide-releasing nanomaterials overcome drug resistance in chemotherapy?Biochem. Pharmacol.202017611374010.1016/j.bcp.2019.113740 31786262
    [Google Scholar]
  6. HidmiA. AlzahayqaM. ErikatS. BaharR. HindiL. Al-MaharikN. SalahZ. Nitric oxide-releasing NO–curcumin hybrid inhibits colon cancer cell proliferation and induces cell death in vitro.Processes (Basel)202210580010.3390/pr10050800
    [Google Scholar]
  7. MorbidelliL. DonniniS. ZicheM. Role of Nitric Oxide in Tumor Angiogenesis. Angiogenesis in Brain Tumors KirschM. BlackP.McL. Springer US2004Vol. 11715516710.1007/978‑1‑4419‑8871‑3_11
    [Google Scholar]
  8. WinkD.A. HinesH.B. ChengR.Y.S. SwitzerC.H. Flores-SantanaW. VitekM.P. RidnourL.A. ColtonC.A. Nitric oxide and redox mechanisms in the immune response.J. Leukoc. Biol.201189687389110.1189/jlb.1010550 21233414
    [Google Scholar]
  9. LiC.Y. AnuragaG. ChangC.P. WengT.Y. HsuH.P. TaH.D.K. SuP.F. ChiuP.H. YangS.J. ChenF.W. YeP.H. WangC.Y. LaiM.D. Repurposing nitric oxide donating drugs in cancer therapy through immune modulation.J. Exp. Clin. Cancer Res.20234212210.1186/s13046‑022‑02590‑0 36639681
    [Google Scholar]
  10. HuangZ. FuJ. ZhangY. Nitric oxide donor-based cancer therapy: Advances and prospects.J. Med. Chem.201760187617763510.1021/acs.jmedchem.6b01672 28505442
    [Google Scholar]
  11. LiH.T. ZhuX. Quinoline-based compounds with potential activity against drugresistant cancers.Curr. Top. Med. Chem.202121542643710.2174/18734294MTA3pNDMx4 32552650
    [Google Scholar]
  12. Ayala-AguileraC.C. ValeroT. Lorente-MacíasÁ. BaillacheD.J. CrokeS. Unciti-BrocetaA. Small molecule kinase inhibitor drugs (1995–2021): medical indication, pharmacology, and synthesis.J. Med. Chem.20226521047113110.1021/acs.jmedchem.1c00963 34624192
    [Google Scholar]
  13. MartoranaA. La MonicaG. LauriaA. Quinoline-based molecules targeting c-Met, EGF, and VEGF receptors and the proteins involved in related carcinogenic pathways.Molecules20202518427910.3390/molecules25184279 32961977
    [Google Scholar]
  14. El-FakharanyZ.S. NissanY.M. SedkyN.K. ArafaR.K. Abou-SeriS.M. New proapoptotic chemotherapeutic agents based on the quinolone-3-carboxamide scaffold acting by VEGFR-2 inhibition.Sci. Rep.20231311134610.1038/s41598‑023‑38264‑w 37443185
    [Google Scholar]
  15. PaoW. MillerV. ZakowskiM. DohertyJ. PolitiK. SarkariaI. SinghB. HeelanR. RuschV. FultonL. MardisE. KupferD. WilsonR. KrisM. VarmusH. EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib.Proc. Natl. Acad. Sci. USA200410136133061331110.1073/pnas.0405220101 15329413
    [Google Scholar]
  16. VincentA. HermanJ. SchulickR. HrubanR.H. GogginsM. Pancreatic cancer.Lancet2011378979160762010.1016/S0140‑6736(10)62307‑0 21620466
    [Google Scholar]
  17. ZongY. PegramM.D. Anti–epidermal growth factor receptor monoclonal antibodies in triple-negative breast cancer.Cancer J.20131915662
    [Google Scholar]
  18. MendelsohnJ. BaselgaJ. The EGF receptor family as targets for cancer therapy.Oncogene200019566550656510.1038/sj.onc.1204082 11426640
    [Google Scholar]
  19. SugasawaT. ToyodaT. AdachiM. SasakuraK. Aminohaloborane in organic synthesis. 1. Specific ortho substitution reaction of anilines.J. Am. Chem. Soc.1978100154842485210.1021/ja00483a034
    [Google Scholar]
  20. TverdokhlebovA. DegtyarenkoA. TolmachevA. VolovenkoY. Chlorotrimethylsilane-mediated friedländer synthesis of 2-(α-chloroalkyl)quinoline derivatives.Synthesis20072007243891389510.1055/s‑2007‑990869
    [Google Scholar]
  21. FotopoulouT. IliodromitisE.K. KoufakiM. TsotinisA. ZogaA. GizasV. PyriochouA. PapapetropoulosA. AndreadouI. KremastinosD.T. Design and synthesis of nitrate esters of aromatic heterocyclic compounds as pharmacological preconditioning agents.Bioorg. Med. Chem.20081684523453110.1016/j.bmc.2008.02.051 18328715
    [Google Scholar]
  22. ParkJ.H. LiuY. LemmonM.A. RadhakrishnanR. Erlotinib binds both inactive and active conformations of the EGFR tyrosine kinase domain.Biochem. J.2012448341742310.1042/BJ20121513 23101586
    [Google Scholar]
  23. PattarS.V. AdhoniS.A. KamanavalliC.M. KumbarS.S. In silico molecular docking studies and MM/GBSA analysis of coumarin-carbonodithioate hybrid derivatives divulge the anticancer potential against breast cancer.Beni. Suef Univ. J. Basic Appl. Sci.2020913610.1186/s43088‑020‑00059‑7
    [Google Scholar]
  24. TolosaL. DonatoM.T. Gómez-LechónM.J. General cytotoxicity assessment by means of the MTT assay.Methods Mol. Biol.20151250333348
    [Google Scholar]
  25. LingY. YeX. JiH. ZhangY. LaiY. PengS. TianJ. Synthesis and evaluation of nitric oxide-releasing derivatives of farnesylthiosalicylic acid as anti-tumor agents.Bioorg. Med. Chem.201018103448345610.1016/j.bmc.2010.03.077 20435479
    [Google Scholar]
  26. IglesiasE. CasadoJ. Mechanisms of hydrolysis and nitrosation reactions of alkyl nitrites in various media.Int. Rev. Phys. Chem.2002211377410.1080/01442350110092693
    [Google Scholar]
  27. OaeS. AsaiN. FujimoriK. Alkaline hydrolyses of alkyl nitrites and related carboxylic esters.J. Chem. Soc., Perkin Trans.1978257157710.1039/p29780000571
    [Google Scholar]
  28. DurchscheinK. HallM. FaberK. Unusual reactions mediated by FMN-dependent ene- and nitro-reductases.Green Chem.2013157176410.1039/c3gc40588e
    [Google Scholar]
/content/journals/acamc/10.2174/0118715206315415240830052608
Loading
/content/journals/acamc/10.2174/0118715206315415240830052608
Loading

Data & Media loading...

Supplements

Supplementary material is available on the publisher's website along with the published article.


  • Article Type:
    Research Article
Keyword(s): EGFR; molecular docking; MTT assay; nitric oxide release; pancreatic cancer; Quinoline
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test